Additionally, kinase-independent effects of CDK8 have also been previously described in melanoma cells and hematologic malignancies [16, 52, 53], while the effect of CDK8 on ER+ breast cancer progression is kinase dependent [17]. Here, CDK8 is linked to breast carcinoma.